Jie Song

Jie Song


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JLJing Li
Jing Li
SYShuyu Yan
Shuyu Yan
XYXiaoqiao Yang
Xiaoqiao Yang
XRXiming Ren
Ximing Ren
HQHongying Qu
Hongying Qu
JSJie Song
Jie Song

20 July 2020 in Aging
Verified
Journal Article
Open access
JLJing Li
Jing Li
TXTingting Xia
Tingting Xia
JCJunyan Cao
Junyan Cao
DHDonghong He
Donghong He
ZCZhaocong Chen
Zhaocong Chen
JSJie Song
Jie Song
Objective: An increasing number of studies have indicated that long noncoding RNAs (lncRNAs) play an important role in the pathogenesis of hepatocellular carcinoma (HCC). In this study, we aimed to clarify the roles of RP11-295G20.2 in HCC progression and the underlying molecular mechanisms. Results: Bioinformatics analyses based TCGA data suggested that RP11-295G20.2 was significantly upregulated in HCC tissues and increased RP11-295G20.2 expression level correlated with poor overall survival of patients with HCC. The results of RT-PCR further showed that RP11-295G20.2 was upregulated in HCC tissues and cell lines. Functionally, RP11-295G20.2 knockdown significantly inhibited the proliferation, colony formation, invasion and migration, but induced the apoptosis of HCC cells. In line with this, downregulation of RP11-295G20.2 in HCC lines markedly suppressed the tumor growth in vivo. Mechanistically, RP11-295G20.2 could upregulate CCNB1 through targeting miR-6884-3p. More importantly, our rescue experiments revealed that miR- 6884-3p/CCNB1 axis was involved in RP11-295G20.2-meditated tumorigenic behaviors of HCC cells. Conclusions: RP11-295G20.2 can contribute to HCC progression at least partly via the miR-6884-3p/CCNB1 axis, suggesting that RP11-295G20.2 may be a potential target for HCC therapy. Methods: RT-qPCR was employed to examine the expression levels of RP11-295G20.2, miR-6884-3p, and CCNB1 in HCC tissues and cell lines. CCK8 assay, transwell assay, colony formation assay and flow cytometry analysis were performed to evaluate the biological function of RP11-295G20.2 in HCC cells. The xenograft tumor assay was used to assess the effect of RP11-295G20.2 on the in vivo growth of HCC cells. The luciferase reporter assay, RIP assay and Spearman's correlation analysis were performed to explore the potential mechanisms underlying the roles of RP11-295G20.2 in HCC progression.

1 July 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
XLXiang-Guang Li
Xiang-Guang Li
HLHuantao Li
Huantao Li
DLDing Luo
Ding Luo
JLJie Li
Jie Li
YWYu Wang
Yu Wang
XCXiao Chuqiao
Xiao Chuqiao